1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Press Release
Marketwired
Articles 

Report: Exploring Fundamental Drivers Behind Aclaris Therapeutics, Extreme Networks, Care, Air Lease, Globus Medical, and Heron Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments

November 27, 2018 | About:

NEW YORK, Nov. 27, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aclaris Therapeutics, Inc. (NASDAQ:ACRS), Extreme Networks, Inc. (NASDAQ:EXTR), Care.com, Inc. (:CRCM), Air Lease Corporation (:AL), Globus Medical, Inc. (:GMED), and Heron Therapeutics, Inc. (NASDAQ:HRTX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ACRS DOWNLOAD: http://Fundamental-Markets.com/register/?so=ACRS
EXTR DOWNLOAD: http://Fundamental-Markets.com/register/?so=EXTR
CRCM DOWNLOAD: http://Fundamental-Markets.com/register/?so=CRCM
AL DOWNLOAD: http://Fundamental-Markets.com/register/?so=AL
GMED DOWNLOAD: http://Fundamental-Markets.com/register/?so=GMED
HRTX DOWNLOAD: http://Fundamental-Markets.com/register/?so=HRTX

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Aclaris Therapeutics, Inc. (NASDAQ:ACRS), Extreme Networks, Inc. (NASDAQ:EXTR), Care.com, Inc. (:CRCM), Air Lease Corporation (:AL), Globus Medical, Inc. (:GMED), and Heron Therapeutics, Inc. (NASDAQ:HRTX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 23rd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ACLARIS THERAPEUTICS, INC. (NASDAQ:ACRS) REPORT OVERVIEW

Aclaris Therapeutics' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Aclaris Therapeutics reported revenue of $1.63MM vs $0.68MM (up 138.01%) and analysts estimated basic earnings per share -$1.06 vs -$0.63. Analysts expect earnings to be released on March 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.80. The estimated EPS forecast for the next fiscal year is -$3.54 and is expected to report on March 11th, 2019.

To read the full Aclaris Therapeutics, Inc. (NASDAQ:ACRS) report, download it here: http://Fundamental-Markets.com/register/?so=ACRS

-----------------------------------------

EXTREME NETWORKS, INC. (NASDAQ:EXTR) REPORT OVERVIEW

Extreme Networks' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Extreme Networks reported revenue of $239.89MM vs $211.72MM (up 13.31%) and analysts estimated basic earnings per share -$0.08 vs $0.04. For the twelve months ended June 30th, 2018 vs June 30th, 2017, Extreme Networks reported revenue of $983.14MM vs $607.08MM (up 61.94%) and analysts estimated basic earnings per share -$0.41 vs -$0.02. Analysts expect earnings to be released on February 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.09. The estimated EPS forecast for the next fiscal year is $0.56 and is expected to report on August 14th, 2019.

To read the full Extreme Networks, Inc. (NASDAQ:EXTR) report, download it here: http://Fundamental-Markets.com/register/?so=EXTR

-----------------------------------------

CARE.COM, INC. (NYSE:CRCM) REPORT OVERVIEW

Care's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Care reported revenue of $49.16MM vs $44.54MM (up 10.38%) and analysts estimated basic earnings per share $0.03 vs -$0.01. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Care reported revenue of $174.09MM vs $161.75MM (up 7.63%) and analysts estimated basic earnings per share $0.23 vs $0.10 (up 130.00%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.11. The estimated EPS forecast for the next fiscal year is $0.29 and is expected to report on February 26th, 2019.

To read the full Care.com, Inc. (NYSE:CRCM) report, download it here: http://Fundamental-Markets.com/register/?so=CRCM

-----------------------------------------

AIR LEASE CORPORATION (NYSE:AL) REPORT OVERVIEW

Air Lease's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Air Lease reported revenue of $450.70MM vs $376.77MM (up 19.62%) and basic earnings per share $1.41 vs $0.96 (up 46.88%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Air Lease reported revenue of $1,516.38MM vs $1,419.06MM (up 6.86%) and analysts estimated basic earnings per share $7.33 vs $3.65 (up 100.82%). Analysts expect earnings to be released on February 28th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.06. The estimated EPS forecast for the next fiscal year is $5.49 and is expected to report on February 28th, 2019.

To read the full Air Lease Corporation (NYSE:AL) report, download it here: http://Fundamental-Markets.com/register/?so=AL

-----------------------------------------

GLOBUS MEDICAL, INC. (NYSE:GMED) REPORT OVERVIEW

Globus Medical's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Globus Medical reported revenue of $169.24MM vs $151.74MM (up 11.53%) and analysts estimated basic earnings per share $0.36 vs $0.27 (up 33.33%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Globus Medical reported revenue of $635.98MM vs $563.99MM (up 12.76%) and analysts estimated basic earnings per share $1.12 vs $1.09 (up 2.75%). Analysts expect earnings to be released on February 20th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.38. The estimated EPS forecast for the next fiscal year is $1.76 and is expected to report on February 20th, 2019.

To read the full Globus Medical, Inc. (NYSE:GMED) report, download it here: http://Fundamental-Markets.com/register/?so=GMED

-----------------------------------------

HERON THERAPEUTICS, INC. (NASDAQ:HRTX) REPORT OVERVIEW

Heron Therapeutics' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Heron Therapeutics reported revenue of $19.79MM vs $8.57MM (up 130.82%) and analysts estimated basic earnings per share -$0.49 vs -$0.77. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Heron Therapeutics reported revenue of $30.77MM vs $1.28MM (up 2,305.55%) and analysts estimated basic earnings per share -$3.65 vs -$4.56. Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$1.09. The estimated EPS forecast for the next fiscal year is -$0.80 and is expected to report on February 26th, 2019.

To read the full Heron Therapeutics, Inc. (NASDAQ:HRTX) report, download it here: http://Fundamental-Markets.com/register/?so=HRTX

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected]

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected]

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

ti?nf=NzQzNjgxMSMyNjA4NDA1IzUwMDAyNzg3MA

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by Marketwired


User Generated Screeners


mmills1518Screen #1
allenmcgaughey20190222
kltan12CANSLIM
PortfolioPlusEV/EBIT Screener
jm.football1Test1
msacaccioSafal Niveshak
jbostwickosv growth small sort by marke
TarunEarngs gth, buybacks 0
TarunEarngs gth, buybacks
TarunP/S, buybacks
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK